FIELD: medicine. SUBSTANCE: present invention describes biologically active compounds, more particularly arylaliphatic aminoazides of general formula I: 
wherein when R is CH2OC6H5,, then R1 is NC4H8O, and n is 4,5, 6 and 7; R1 is NC5H10,, and n is 4,5,6 and 7; when R is CH2OC6H4CH3-4, then R1 is N(CH3)2,, and n is 4,5,6 and 7; when R is CH2OC6H4CH3-2,, then R1 is NC5H10, and n is 4,5,6 and 7; when R is CH2OC6H4OCH3-2, then R1 is N(CH3)2, and n is 4,5,6 and 7; when R is CH2OC6H4NO2-4, then R1 is N(C2H5)2, and n is 4,5,6,7; when R is CH2OC6H4F-4, then R1 is NC5H10, and n is 4,5,6,7; when R is CH2OC6H4Br-4, then R1 is N(CH3)2,, and n is 4,5,6,7; when R is CH2OC6H4Cl-2, then R1 is NC5H10, and n is 4,5,6 and 7; R1 is N(CH3)2 and n is 4,5,6 and 7; when R is CH2OC6H4Cl-3, then R1 is NC4H8O, and n is 4,5,6 and 7; when R1 is N(CH3)2 and n is 4,5,6 and 7; when R is CH2OC6H4Cl-4, then R1/ is NC4H8O, and n is 4,5,6 and 7; when R1 is NC5H10, and n is 4,5,6,7; when R is CH2OC6H3Cl2-2,4, then R1 is N(CH3)2, and n is 4,5,6 and 7; when R1 is NC5H10, and n is 4,5,6 and 7; when R1 is N(C2H5)2, and n is 4,5,6,7; when R1 is NC4H8O and n is 4,5,6,7; when R is CH2OC6H3Cl-2, then R1 is NC4H8O, and n is 4,5,6,7; when R is CH2OC6H3Cl2-2,5, then R1 is NC5H10, and n is 4,5,6,7; when R is CH2OC6H3Cl2-2,6, then R1 is N(CH3)2 and n is 4,5,6,7; having antiarythmic and local anesthetic and analgetic activity. Azidoamides are low-loxic agents and have pronounced antiarythmic properties which are superior than drugs such as guinidine, novocaineamide, lidocaine and ethacizine used in medical practice. Said compounds also have pronounced local anesthetic activity and central analgetic effect, but they are as effective as well known drugs such as trimecaine and analgin currently used in medical practice. They are promising for developing new highly effective drugs for local anesthesia, analgesia and medical treatment of disorders of cardiac rhythm. EFFECT: improved properties of the title compounds. 84 ex, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FUNCTIONALLY SUBSTITUTED 1-PHENYLOLIGOOXYETHYLAMINES MANIFESTING ANTIARRYTHMIC ACTIVITY | 1997 |
|
RU2141941C1 |
| ARYLALIPHATIC AMINOAMIDES OF BENZOIC (SUBSTITUTED BENZOIC), CYCLOHEXANE- AND 1-ADAMANTANE CARBOXYLIC ACIDS SHOWING ANTI-ARRHYTHMIC, TOPICAL ANESTHETIC AND ANALGETIC ACTIVITY | 1996 |
|
RU2130922C1 |
| N,N-BIS(2-(DIALKYLAMINO)ETHYL)CARBOXAMIDES AND THEIR DIHYDROCHLORIDES WITH ANTIARRHYTHMIC ACTIVITY AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2017 |
|
RU2645080C1 |
| N-(2-(2-(DIALKYLAMINO)ETHOXY)ETHYL)CARBOXAMIDES AND HYDROCHLORIDES THEREOF, HAVING ANTIARRHYTHMIC ACTIVITY, AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2019 |
|
RU2712638C1 |
| 2-(2-(DIALKYLAMINO POLYETHOXY))ETHYL CARBOXYLATES AND HYDROCHLORIDES THEREOF WITH ANTIARRHYTHMIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2020 |
|
RU2775616C2 |
| VERSIONS OF METHOD OF PRODUCING DERIVATIVES OF 3-AZABACYCLO [3,3,1]NONANE OR ISOMERS THEREOF,OR PHARMACEUTICALLY ACCEPTABLE SALTS OF ACID ADDITION THEREOF | 0 |
|
SU1395141A3 |
| ARYL CONDENSED 2,4-DIAZEPINE COMPOUNDS, INTERMEDIATE PRODUCTS, ANTIARRHYTHMIC AGENT, AND COMPOSITION | 1991 |
|
RU2114833C1 |
| METHOD OF PRODUCING POLY-N,N-DIMETHYL-3,4- DIMETHYLENEPYRROLIDINIUM CHLORIDE | 2008 |
|
RU2372333C1 |
| AMINOCARBOXYLIC ACID AMIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2134683C1 |
| METHOD FOR PRODUCING N-ARYL-ALPHA-AMINOCARBOXAMIDES OR THEIR SALTS WITH PHARMACEUTICALLY ACCEPTABLE ACID OR POSSIBLE STEREOCHEMICAL ISOMERIC FORM | 0 |
|
SU1313344A3 |
